The Protein Kinase Activity of NME7 Activates Wnt/{beta}-Catenin Signaling to Promote One-Carbon Metabolism in Hepatocellular Carcinoma
Xinxin Ren,Zhuoxian Rong,Xiaoyu Liu,Jie Gao,Xu Xu,Yuyuan Zi,Yun Mu,Yidi Guan,Zhen Cao,Yuefang Zhang,Zimei Zeng,Qi Fan,Xitao Wang,Qian Pei,Xiang Wang,Haiguang Xin,Zhi Li,Yingjie Nie,Zilong Qiu,Nan Li,Lunquan Sun,Yuezhen Deng
DOI: https://doi.org/10.1158/0008-5472.can-21-1020
IF: 11.2
2022-01-05
Cancer Research
Abstract:Metabolic reprogramming by oncogenic signaling is a hallmark of cancer. Hyperactivation of Wnt/β-catenin signaling has been reported in hepatocellular carcinoma (HCC). However, the mechanisms inducing hyperactivation of Wnt/β-catenin signaling and strategies for targeting this pathway are incompletely understood. In this study, we find nucleoside diphosphate kinase 7 (NME7) to be a positive regulator of Wnt/β-catenin signaling. Upregulation of NME7 positively correlated with the clinical features of HCC. Knockdown of NME7 inhibited HCC growth in vitro and in vivo, whereas overexpression of NME7 cooperated with c-Myc to drive tumorigenesis in a mouse model and to promote the growth of tumor-derived organoids. Mechanistically, NME7 bound and phosphorylated serine 9 of GSK3β to promote β-catenin activation. Furthermore, MTHFD2, the key enzyme in one-carbon metabolism, was a target gene of β-catenin and mediated the effects of NME7. Tumor-derived organoids with NME7 overexpression exhibited increased sensitivity to MTHFD2 inhibition. In addition, expression levels of NME7, β-catenin, and MTHFD2 correlated with each other and with poor prognosis in patients with HCC. Collectively, this study emphasizes the crucial roles of NME7 protein kinase activity in promoting Wnt/β-catenin signaling and one-carbon metabolism, suggesting NME7 and MTHFD2 as potential therapeutic targets for HCC.Significance:The identification of NME7 as an activator of Wnt/β-catenin signaling and MTHFD2 expression in HCC reveals a mechanism regulating one-carbon metabolism and potential therapeutic strategies for treating this disease.
oncology